Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Angelica Cortez

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 18, 2020
Use of Multi-Site Radiation Therapy for Systemic Disease ControlRoshal R Patel, Vivek Verma, Hampartsoum B Barsoumian, et al.
Translational Oncology|December 19, 2020
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activityAhmed I Younes, Hampartsoum B Barsoumian, Duygu Sezen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2019
Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune ResponsesMauricio S Caetano, Ahmed I Younes, Hampartsoum B Barsoumian, et al.
Genes, Chromosomes & Cancer|July 29, 2010
miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastomaMaria Angelica Cortez, Milena Sabrina Nicoloso, Masayoshi Shimizu, et al.
Journal of the National Cancer Institute|November 19, 2015
PDL1 Regulation by p53 via miR-34Maria Angelica Cortez, Cristina Ivan, David Valdecanas, et al.
Nature Communications|September 25, 2020
Bone morphogenetic protein 7 promotes resistance to immunotherapyMaria Angelica Cortez, Fatemeh Masrorpour, Cristina Ivan, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 5, 2024
Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapyYun Hu, Alexey Revenko, Hampartsoum Barsoumian, et al.
Nature Communications|October 9, 2020
Author Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapyMaria Angelica Cortez, Fatemeh Masrorpour, Cristina Ivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2023
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive TumorsLuana Guimaraes Sousa, Daniel J McGrail, Felippe Lazar Neto, et al.
Cancer Research|August 19, 2015
Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical CarcinomaLiem M Phan, Enrique Fuentes-Mattei, Weixin Wu, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|August 18, 2020
Use of Multi-Site Radiation Therapy for Systemic Disease ControlRoshal R Patel, Vivek Verma, Hampartsoum B Barsoumian, et al.
Translational Oncology|December 19, 2020
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activityAhmed I Younes, Hampartsoum B Barsoumian, Duygu Sezen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2019
Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune ResponsesMauricio S Caetano, Ahmed I Younes, Hampartsoum B Barsoumian, et al.
Genes, Chromosomes & Cancer|July 29, 2010
miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastomaMaria Angelica Cortez, Milena Sabrina Nicoloso, Masayoshi Shimizu, et al.
Journal of the National Cancer Institute|November 19, 2015
PDL1 Regulation by p53 via miR-34Maria Angelica Cortez, Cristina Ivan, David Valdecanas, et al.
Nature Communications|September 25, 2020
Bone morphogenetic protein 7 promotes resistance to immunotherapyMaria Angelica Cortez, Fatemeh Masrorpour, Cristina Ivan, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 5, 2024
Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapyYun Hu, Alexey Revenko, Hampartsoum Barsoumian, et al.
Nature Communications|October 9, 2020
Author Correction: Bone morphogenetic protein 7 promotes resistance to immunotherapyMaria Angelica Cortez, Fatemeh Masrorpour, Cristina Ivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2023
Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive TumorsLuana Guimaraes Sousa, Daniel J McGrail, Felippe Lazar Neto, et al.
Cancer Research|August 19, 2015
Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical CarcinomaLiem M Phan, Enrique Fuentes-Mattei, Weixin Wu, et al.
Pageof 7